Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Asthma Therapeutics Market Set To Climb From $35.73 Billion In 2026 To $47.87 Billion By 2030
The asthma therapeutics market has experienced strong expansion in recent years. It is anticipated to increase from $33.11 billion in 2025 to $35.73 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.9%. The market’s past growth can be attributed to the limited accessibility of biologics, the widespread use of short-acting beta agonists, the increasing global incidence of asthma, a surge in hospital and specialty clinic visits, and the common adoption of oral and inhaled medications.
The asthma therapeutics market is projected to experience substantial expansion in the coming years, reaching a valuation of $47.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.6%. This anticipated growth during the forecast period is driven by factors such as the emergence of new biologics and combined treatment approaches, the broader adoption of telemedicine and digital health surveillance, heightened public understanding of preventive care, improved access to healthcare services in developing regions, and increased funding for drug research and development. Key trends anticipated during this period encompass the increasing embrace of tailored asthma treatments, a surge in the use of inhalers and biologics, the proliferation of homecare and distant monitoring technologies, a rising inclination towards combination inhalers, and a stronger emphasis on asthma management for both pediatric and elderly patients.
Get A Free Sample Report With In-Depth Market Insights:
Asthma Therapeutics Market Growth Drivers: What’s Behind The Acceleration?
The rising occurrence of asthma is anticipated to drive the expansion of the asthma therapeutics market in the future. Asthma is a chronic condition characterized by inflammation and swelling in the airways, leading to their constriction, which impedes air passage from the nose and mouth to the lungs. The growing incidence of asthma can be attributed to heightened levels of pollutants, which irritate the respiratory passages and elevate the likelihood of developing this illness. Asthma therapeutics are instrumental in managing the condition by regulating inflammation in the airways, alleviating symptoms, and averting asthma episodes. For example, data from the UK Parliament, a UK government institution, indicated that in May 2025, approximately 3,886,879 individuals over six years old had an asthma diagnosis in 2023-24, representing 6.5% of England’s population. Consequently, the expanding prevalence of asthma is a key factor propelling the growth of the asthma therapeutics market.
Asthma Therapeutics Market Segmentation And Category Overview
The asthma therapeutics market covered in this report is segmented –
1) By Drug Class: Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)
2) By Treatment Stage: Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications
3) By Route Of administration: Oral, Inhaled, Intravenous, Subcutaneous
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End-User: Hospitals, Homecare, Specialty Clinics
Subsegments:
1) By Inhaled Corticosteroids (ICS): Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide
2) By Long-Acting Beta Agonists (LABA): Salmeterol, Formoterol, Indacaterol, Olodaterol
3) By Leukotriene Receptor Antagonists (LTRA): Montelukast, Zafirlukast, Pranlukast
4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol), Levalbuterol, Terbutaline
5) By Biologics: Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab
6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol
Asthma Therapeutics Market Trends: What’s Defining The Industry’s Next Phase?
Companies within the asthma therapeutics market are prioritizing the creation of advanced solutions, such as anti-inflammatory rescue inhalers, to improve symptom relief, manage inflammation, and enhance overall disease management. This type of rescue inhaler represents a dual-action therapeutic strategy, integrating a rapid-acting bronchodilator with an inhaled corticosteroid within a single device, which enables quick bronchodilation, immediate inflammation reduction when needed, and helps avert severe asthma attacks. As an illustration, in January 2024, the UK-based biopharmaceutical firm AstraZeneca plc introduced AIRSUPRA, an anti-inflammatory rescue inhaler that received FDA approval. It is designed to provide rapid symptom alleviation along with swift anti-inflammatory effects, offering dual-mechanism dosing as required, real-time suppression of airway inflammation, and assistance in preventing lung-function deterioration linked to exacerbations. AIRSUPRA contributes to better asthma control, lowers the likelihood of severe attacks, and enhances the overall efficacy of rescue therapies.
Asthma Therapeutics Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mylan N.V.
View The Full Asthma Therapeutics Market Report:
Asthma Therapeutics Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the asthma therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model